Company / Operating Cash Flow
CASTLE BIOSCIENCES INC Operating Cash Flow History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$64.3M
FY2025
5-year range
-$41.7M / $64.9M
FY2021-FY2025
Trend
-0.8%
vs FY2024
Sector context
#116 of 163
Health Care
What the data says
At $64M, CASTLE BIOSCIENCES INC's operating cash flow ranks #116 of 163 in the Health Care sector. Operating Cash Flow has fluctuated over the past 8 years, ranging from -$42M in FY2022 to $65M in FY2024.
Based on SEC 10-K filings.
$64M in FY2025 with a 5-year CAGR of +45.5%.
Improved from -$6M to $64M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +45.5%
- 10-Year CAGR
- -
Sector benchmark
#116 of 163 in Health CareTop 71% of 163This company $64.3M Sector average $1.0B
▼
-93.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +45.5%, indicating consistent growth.
- In FY2025, operating cash flow decreased 0.8% year-over-year.
- Ranks #116 out of 163 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $64.3M | -0.8% |
| FY2024 | $64.9M | +1253.0% |
| FY2023 | -$5.6M | +86.5% |
| FY2022 | -$41.7M | -119.4% |
| FY2021 | -$19.0M | -292.4% |
| FY2020 | $9.9M | +40.6% |
| FY2019 | $7.0M | +157.1% |
| FY2018 | -$12.3M | - |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026